- Home
- News
- Topics
- FDA Week
- Inside CMS
- Inside Drug Pricing
- Health Exchange Alert
- Inside TeleHealth
- About Us
Senate health committee Chair Bill Cassidy (R-LA) on Thursday (April 24) released the findings of a years-long staff investigation of the 340B drug discount program and listed legislative reforms he may push to rein in practices by safety net providers and contract pharmacies that prevent patients from directly benefiting from the discounts.
Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.
Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.
© 2002-2025. Inside Washington Publishers | Contact Us